Latest Aerska News & Updates

See the latest news and media coverage for Aerska. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Aerska

Biotechnology company developing brain-targeted RNA medicines

aerska.com
Headquarters
Dublin, Ireland
Company type
Private company
Number of employees
39–50

Last updated

Latest news about Aerska

In short: Aerska raised $39 million in a Series A to advance its brain-shuttle RNAi platform.

Company announcements

Aerska

Aerska raises $39M Series A financing

The round was led by EQT Dementia Fund and age1, bringing total raised to $60 million; proceeds advance its brain shuttle RNAi platform, and three directors join the board.

Aerska

Aerska launches with $21M seed financing for brain RNAi medicines

The round is co-led by Age1, Backed VC and Speedinvest, and funds an antibody-oligo conjugate platform using brain shuttles to silence genes behind Alzheimer's and Parkinson's.

Unlock all announcements with a

Media coverage

Yahoo Finance

A new biotech aims to get RNA drugs into the brain

Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA interference medicines past the...

Unlock all articles with a

Never miss news about Aerska

Track Aerska and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.